Skip to main content
Erschienen in: Current Hematologic Malignancy Reports 3/2018

28.04.2018 | Health Economics (N Khera, Section Editor)

The Effect of Psychosocial Interventions on Outcomes for Caregivers of Hematopoietic Cell Transplant Patients

verfasst von: Lauren R. Bangerter, Joan M. Griffin, Shelby Langer, Bashar Hasan, Wonsun (Sunny) Kim, M. Hassan Murad, Nandita Khera

Erschienen in: Current Hematologic Malignancy Reports | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Hematopoietic cell transplant (HCT) patients are required to have a caregiver present for up to 100 days post-transplant. Caregivers provide essential support during HCT but experience immense stress and burden. Increasing research has developed interventions for HCT caregivers. This review systematically evaluates psychosocial interventions for caregivers of HCT patients.

Recent Findings

The search yielded 12 studies (7 efficacy and 5 feasibility studies) enrolling 931 caregivers. Interventions were feasible and acceptable as evidenced by high rates of completion (70–100%) with attrition due to patient morbidity or mortality. Feasibility was augmented by flexible delivery (in-person, teleconference, smartphones, or Web-based platforms). Acceptability was demonstrated by objective measures of satisfaction. Effectiveness was found for fatigue and mental health service use, but not for burden, sleep-quality, and inconsistently for caregiver depression, anxiety, coping, and quality of life.

Summary

Psychosocial interventions are feasible, acceptable, and show mixed effects on HCT caregiver outcomes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Majhail NS, Tao L, Bredeson C, Davies S, Dehn J, Gajewski JL, et al. Prevalence of hematopoietic cell transplant survivors in the United States. Biol Blood Marrow Transplant. 2013;19(10):1498–501.CrossRefPubMedPubMedCentral Majhail NS, Tao L, Bredeson C, Davies S, Dehn J, Gajewski JL, et al. Prevalence of hematopoietic cell transplant survivors in the United States. Biol Blood Marrow Transplant. 2013;19(10):1498–501.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Foster LW, McLellan L, Rybicki L, Dabney J, Copelan E, Bolwell B. Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: a prospective study. Bone Marrow Transplant. 2013;48(5):671–7.CrossRefPubMed Foster LW, McLellan L, Rybicki L, Dabney J, Copelan E, Bolwell B. Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: a prospective study. Bone Marrow Transplant. 2013;48(5):671–7.CrossRefPubMed
3.
Zurück zum Zitat Foster LW, McLellan LJ, Rybicki LA, Sassano DA, Hsu A, Bolwell BJ. Survival of patients who have undergone allogeneic bone marrow transplantation: the relative importance of in-hospital lay care-partner support. J Psychosoc Oncol. 2005;22(2):1–20.CrossRef Foster LW, McLellan LJ, Rybicki LA, Sassano DA, Hsu A, Bolwell BJ. Survival of patients who have undergone allogeneic bone marrow transplantation: the relative importance of in-hospital lay care-partner support. J Psychosoc Oncol. 2005;22(2):1–20.CrossRef
4.
Zurück zum Zitat Cooke L, Grant M, Eldredge DH, Maziarz RT, Nail LM. Informal caregiving in hematopoietic blood and marrow transplant patients. Eur J Oncol Nurs. 2011;15(5):500–7.CrossRefPubMedPubMedCentral Cooke L, Grant M, Eldredge DH, Maziarz RT, Nail LM. Informal caregiving in hematopoietic blood and marrow transplant patients. Eur J Oncol Nurs. 2011;15(5):500–7.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Siston AK, List MA, Daugherty CK, Banik DM, Menke C, Cornetta K, et al. Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation. Bone Marrow Transplant. 2001;27(11):1181–8.CrossRefPubMed Siston AK, List MA, Daugherty CK, Banik DM, Menke C, Cornetta K, et al. Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation. Bone Marrow Transplant. 2001;27(11):1181–8.CrossRefPubMed
6.
Zurück zum Zitat Von Ah D, Spath M, Nielsen A, Fife B. The Caregiver’s role across the bone marrow transplantation trajectory. Cancer Nurs. 2016;39(1):E12–9. Von Ah D, Spath M, Nielsen A, Fife B. The Caregiver’s role across the bone marrow transplantation trajectory. Cancer Nurs. 2016;39(1):E12–9.
7.
Zurück zum Zitat Eldredge DH, Nail LM, Maziarz RT, Hansen LK, Ewing D, Archbold PG. Explaining family caregiver role strain following autologous blood and marrow transplantation. J Psychosoc Oncol. 2006;24(3):53–74.CrossRefPubMed Eldredge DH, Nail LM, Maziarz RT, Hansen LK, Ewing D, Archbold PG. Explaining family caregiver role strain following autologous blood and marrow transplantation. J Psychosoc Oncol. 2006;24(3):53–74.CrossRefPubMed
8.
Zurück zum Zitat Bishop MM, Beaumont JL, Hahn EA, Cella D, Andrykowski MA, Brady MJ, et al. Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. J Clin Oncol. 2007;25(11):1403–11.CrossRefPubMed Bishop MM, Beaumont JL, Hahn EA, Cella D, Andrykowski MA, Brady MJ, et al. Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. J Clin Oncol. 2007;25(11):1403–11.CrossRefPubMed
9.
Zurück zum Zitat Langer S, Abrams J, Syrjala K. Caregiver and patient marital satisfaction and affect following hematopoietic stem cell transplantation: a prospective, longitudinal investigation. Psychooncology. 2003;12(3):239–53.CrossRefPubMed Langer S, Abrams J, Syrjala K. Caregiver and patient marital satisfaction and affect following hematopoietic stem cell transplantation: a prospective, longitudinal investigation. Psychooncology. 2003;12(3):239–53.CrossRefPubMed
10.
Zurück zum Zitat Gemmill R, Cooke L, Williams AC, Grant M. Informal caregivers of hematopoietic cell transplant patients: a review and recommendations for interventions and research. Cancer Nurs. 2011;34(6):E13–21.CrossRefPubMedPubMedCentral Gemmill R, Cooke L, Williams AC, Grant M. Informal caregivers of hematopoietic cell transplant patients: a review and recommendations for interventions and research. Cancer Nurs. 2011;34(6):E13–21.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Lazarus RSL, Folkman S. Stress appraisal, and coping. Springer: Publishing Company; 1984. 466 p. Lazarus RSL, Folkman S. Stress appraisal, and coping. Springer: Publishing Company; 1984. 466 p.
12.
15.
Zurück zum Zitat Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343(oct18 2):d5928.CrossRefPubMedPubMedCentral Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343(oct18 2):d5928.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Pensak NA, Joshi T, Simoneau T, Kilbourn K, Carr A, Kutner J, et al. Development of a Web-based intervention for addressing distress in caregivers of patients receiving stem cell transplants: formative evaluation with qualitative interviews and focus groups. JMIR Res Protoc. 2017;6(6):e120.CrossRefPubMedPubMedCentral Pensak NA, Joshi T, Simoneau T, Kilbourn K, Carr A, Kutner J, et al. Development of a Web-based intervention for addressing distress in caregivers of patients receiving stem cell transplants: formative evaluation with qualitative interviews and focus groups. JMIR Res Protoc. 2017;6(6):e120.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat • Simoneau TL, Kilbourn K, Spradley J, Laudenslager ML. An evidence-based stress management intervention for allogeneic hematopoietic stem cell transplant caregivers: development, feasibility and acceptability. Support Care Cancer. 2017;10:1–9. Provides important explanaiton of feasibility study. • Simoneau TL, Kilbourn K, Spradley J, Laudenslager ML. An evidence-based stress management intervention for allogeneic hematopoietic stem cell transplant caregivers: development, feasibility and acceptability. Support Care Cancer. 2017;10:1–9. Provides important explanaiton of feasibility study.
19.
Zurück zum Zitat Heermann JA, Eilers JG, Carney PA. Use of modified OSCEs to verify technical skill performance and competency of lay caregivers. J Cancer Educ. 2001;16(2):93–8.PubMed Heermann JA, Eilers JG, Carney PA. Use of modified OSCEs to verify technical skill performance and competency of lay caregivers. J Cancer Educ. 2001;16(2):93–8.PubMed
20.
Zurück zum Zitat Metoyer LJ. Education of hematopoietic stem cell transplant caregivers in preparation for their role. J Adv Pract Oncol. 2013;4(6):432–7.PubMedPubMedCentral Metoyer LJ. Education of hematopoietic stem cell transplant caregivers in preparation for their role. J Adv Pract Oncol. 2013;4(6):432–7.PubMedPubMedCentral
21.
Zurück zum Zitat Bevans M, Castro K, Prince P, Shelburne N, Prachenko O, Loscalzo M, et al. An individualized dyadic problem-solving education intervention for patients and family caregivers during allogeneic hematopoietic stem cell transplantation: a feasibility study. Cancer Nurs. 2010;33(2):E24–32.CrossRefPubMedPubMedCentral Bevans M, Castro K, Prince P, Shelburne N, Prachenko O, Loscalzo M, et al. An individualized dyadic problem-solving education intervention for patients and family caregivers during allogeneic hematopoietic stem cell transplantation: a feasibility study. Cancer Nurs. 2010;33(2):E24–32.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Bevans M, Wehrlen L, Castro K, Prince P, Shelburne N, Soeken K, et al. A problem-solving education intervention in caregivers and patients during allogeneic hematopoietic stem cell transplantation. J Health Psychol. 2014;19(5):602–17.CrossRefPubMed Bevans M, Wehrlen L, Castro K, Prince P, Shelburne N, Soeken K, et al. A problem-solving education intervention in caregivers and patients during allogeneic hematopoietic stem cell transplantation. J Health Psychol. 2014;19(5):602–17.CrossRefPubMed
23.
Zurück zum Zitat El-Jawahri A, LeBlanc T, VanDusen H, Traeger L, Greer JA, Pirl WF, et al. Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA. 2016;316(20):2094–103.CrossRefPubMedPubMedCentral El-Jawahri A, LeBlanc T, VanDusen H, Traeger L, Greer JA, Pirl WF, et al. Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA. 2016;316(20):2094–103.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Fife BL, Von Ah DM, Spath ML, Weaver MT, Yang Z, Stump T, et al. Preliminary efficacy of a brief family intervention to prevent declining quality of life secondary to parental bone marrow transplantation. Bone Marrow Transplant. 2017;52(2):285–91.CrossRefPubMed Fife BL, Von Ah DM, Spath ML, Weaver MT, Yang Z, Stump T, et al. Preliminary efficacy of a brief family intervention to prevent declining quality of life secondary to parental bone marrow transplantation. Bone Marrow Transplant. 2017;52(2):285–91.CrossRefPubMed
25.
Zurück zum Zitat Laudenslager ML, Simoneau TL, Kilbourn K, Natvig C, Philips S, Spradley J, et al. A randomized control trial of a psychosocial intervention for caregivers of allogeneic hematopoietic stem cell transplant patients: effects on distress. Bone Marrow Transplant. 2015;50(8):1110–8.CrossRefPubMedPubMedCentral Laudenslager ML, Simoneau TL, Kilbourn K, Natvig C, Philips S, Spradley J, et al. A randomized control trial of a psychosocial intervention for caregivers of allogeneic hematopoietic stem cell transplant patients: effects on distress. Bone Marrow Transplant. 2015;50(8):1110–8.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Laudenslager ML, Simoneau TL, Philips S, Benitez P, Natvig C, Cole S. A randomized controlled pilot study of inflammatory gene expression in response to a stress management intervention for stem cell transplant caregivers. J Behav Med. 2016;39(2):346–54.CrossRefPubMed Laudenslager ML, Simoneau TL, Philips S, Benitez P, Natvig C, Cole S. A randomized controlled pilot study of inflammatory gene expression in response to a stress management intervention for stem cell transplant caregivers. J Behav Med. 2016;39(2):346–54.CrossRefPubMed
28.
Zurück zum Zitat Rexilius SJ, Mundt C, Erickson Megel M, Agrawal S. Therapeutic effects of massage therapy and handling touch on caregivers of patients undergoing autologous hematopoietic stem cell transplant. Oncol Nurs Forum. 2002;29(3):E35–44.CrossRefPubMed Rexilius SJ, Mundt C, Erickson Megel M, Agrawal S. Therapeutic effects of massage therapy and handling touch on caregivers of patients undergoing autologous hematopoietic stem cell transplant. Oncol Nurs Forum. 2002;29(3):E35–44.CrossRefPubMed
30.
Zurück zum Zitat Kim Y, Carver CS, Spiegel D, Mitchell H-R, Cannady RS. Role of family caregivers’ self-perceived preparedness for the death of the cancer patient in long-term adjustment to bereavement. Psychooncology. 2017;26(4):484–92.CrossRefPubMed Kim Y, Carver CS, Spiegel D, Mitchell H-R, Cannady RS. Role of family caregivers’ self-perceived preparedness for the death of the cancer patient in long-term adjustment to bereavement. Psychooncology. 2017;26(4):484–92.CrossRefPubMed
31.
Zurück zum Zitat Kent EE, Rowland JH, Northouse L, Litzelman K, Chou W-YS, Shelburne N, et al. Caring for caregivers and patients: research and clinical priorities for informal cancer caregiving. Cancer. 2016;122(13):1987–95.CrossRefPubMedPubMedCentral Kent EE, Rowland JH, Northouse L, Litzelman K, Chou W-YS, Shelburne N, et al. Caring for caregivers and patients: research and clinical priorities for informal cancer caregiving. Cancer. 2016;122(13):1987–95.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat • Langer S, Lehane C, Yi J. Patient and caregiver adjustment to hematopoietic stem cell transplantation: a systematic review of dyad-based studies. Curr Hematol Malig Rep. 2017. Provides a systematic review of dyad-based studies. • Langer S, Lehane C, Yi J. Patient and caregiver adjustment to hematopoietic stem cell transplantation: a systematic review of dyad-based studies. Curr Hematol Malig Rep. 2017. Provides a systematic review of dyad-based studies.
Metadaten
Titel
The Effect of Psychosocial Interventions on Outcomes for Caregivers of Hematopoietic Cell Transplant Patients
verfasst von
Lauren R. Bangerter
Joan M. Griffin
Shelby Langer
Bashar Hasan
Wonsun (Sunny) Kim
M. Hassan Murad
Nandita Khera
Publikationsdatum
28.04.2018
Verlag
Springer US
Erschienen in
Current Hematologic Malignancy Reports / Ausgabe 3/2018
Print ISSN: 1558-8211
Elektronische ISSN: 1558-822X
DOI
https://doi.org/10.1007/s11899-018-0445-y

Weitere Artikel der Ausgabe 3/2018

Current Hematologic Malignancy Reports 3/2018 Zur Ausgabe

Health Economics (N Khera, Section Editor)

Frailty in Hematologic Malignancy

Multiple Myeloma (P Kapoor, Section Editor)

How We Manage Patients with Plasmacytomas

Myeloproliferative Neoplasms (B Stein, Section Editor)

Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.